期刊文献+

肝癌患者射频消融后血清Th1、Th2型细胞因子的变化 被引量:16

Changes of Th1,Th2 cytokines in the serum of patients with hepatocellular carcinoma after radiofrequency ablation
下载PDF
导出
摘要 目的研究肝癌患者射频消融(RFA)治疗后血清Th1、Th2类细胞因子水平的变化,评价射频消融治疗对肝癌患者免疫状态的影响。方法多极射频消融治疗仪(RFA-I)治疗肝癌患者28例,采用流式细胞术检测患者在射频消融前和治疗后1d、21d外周血Th1细胞因子(IL-2、TNF-α)及Th2细胞因子(IL-4、IL-10)。结果肝癌患者治疗前外周血Th1细胞因子(IL-2、TNF-α)降低,Th2细胞因子(IL-4、IL-10)升高,与对照组相比,差异有统计学意义(P<0.05);RFA治疗后外周血Th1细胞因子(IL-2、TNF-α)升高,Th2细胞因子(IL-4、IL-10)降低,与治疗前相比,差异有统计学意义(P<0.05)。结论射频消融治疗可改善肝癌患者机体的免疫功能。 Objective To study the changes of Th1,Th2 type cytokines in the serum of patients with hepatocellular carcinoma(HHC) after radiofrequency ablation(RFA).To evaluate the influence of RFA on immunity function in patients with HHC.Methods Twenty-eight cases of HHC patients were treated using RFA-I radio frequency instrument.Th1 type cytokines(IL-2,TNF-α) and Th2 type cytokines(IL-4,IL-10) in the serum were detected by flow cytometry.Results The level of Th1 type cytokines(IL-2,TNF-α) was significantly lower and Th2 type cytokines(IL-4,IL-10) higher than those of the control group,respectively(P0.05).After treatment with RFA,the level of Th1 type cytokines(IL-2,TNF-α) increased while the level of Th2 type cytokines(IL-4,IL-10) decreased(P0.05).Conclusion Immune function of HHC patients can be improved by the treatment of RFA.
出处 《肝胆胰外科杂志》 CAS 2010年第2期94-96,共3页 Journal of Hepatopancreatobiliary Surgery
关键词 射频消融 肝肿瘤 细胞因子 radio frequency ablation liver neoplasms cytokines
  • 相关文献

参考文献10

  • 1Nielsen DT,Laursen HB,Rokkjaer M,et al.Radiofrequency ablation of malignant liver tumors[J].Ugeskrift for lacger,2002,164 (40):4642-4645.
  • 2Livraghi T,Goldberg SN.Lazzaroni S,et al.Hepatocellular carcmoma:radio-frequency ablation of medium and large lesion[J].Radiology,2003,214(3):761-768.
  • 3Poon RT,Ng KK,Lam CM,et al.Effectiveness of radiofrequency ablation for hepatocellular carcinoma as larger than 3 cm in diameter[J].Arch Surg,2004,139(3):281-287.
  • 4孙婧璟,吴孟超.肝癌复发转移的分子机制[J].中国实用外科杂志,2000,20(3):176-178. 被引量:7
  • 5Fowler DH.Gress RE.Th1 and Th2 cells in the regulation of GVHD,CVL,and graft rejection:considerations for the allogeneic transplation therapy of leukemia and lymphoma[J].Leuk Lymphoma,2006,38(3-4):221 -234.
  • 6Sparano A,Lathers DM.Achille N,et al.Modulation of Th1 and Th2 cytokine profiles and their association with advanced head and neck squamous cell carcinoma[J].Otolaryngol Head Neck Surg,2004,131(5):573-576.
  • 7Seewaldt S,Alferink J,Forster I.Interleukin-10 is crucial for maintenance but not for development induction of peripheral T cell tolerance[J].Eur J Immunol,2005,32(12):3607-3616.
  • 8Zheng Z.Narita M,Takahashi M,et al.Induction of T cell anergy by the treatment with IL-10 treated dendntic cells[J].Comp Immunol Microbiol Infect Dis,2004,27(2):93-103.
  • 9Agarwalal A,Rani M,Saha GK,et al.Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma[J].Immumol Invest,2003,32(1-2):17-30.
  • 10Hess AD,Thobury C,Chen W,et al.The N-terminal flanking region of the immunogenicity of a cryptic "self" epitode from a tumor associated antigen[J].Clin Immunol,2001,101(1):67-76.

二级参考文献25

共引文献6

同被引文献156

引证文献16

二级引证文献186

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部